Literature DB >> 28124074

MRI visible Fe3O4 polypropylene mesh: 3D reconstruction of spatial relation to bony pelvis and neurovascular structures.

Luyun Chen1, Florian Lenz2, Céline D Alt3, Christof Sohn4, John O De Lancey5, Kerstin A Brocker6.   

Abstract

INTRODUCTION AND HYPOTHESIS: To demonstrate mesh magnetic resonance imaging (MRI) visibility in living women, the feasibility of reconstructing the full mesh course in 3D, and to document its spatial relationship to pelvic anatomical structures.
METHODS: This is a proof of concept study of three patients from a prospective multi-center trial evaluating women with anterior vaginal mesh repair using a MRI-visible Fe3O4 polypropylene implant for pelvic floor reconstruction. High-resolution sagittal T2-weighted (T2w) sequences, transverse T1-weighted (T1w) FLASH 2D, and transverse T1w FLASH 3D sequences were performed to evaluate Fe3O4 polypropylene mesh MRI visibility and overall post-surgical pelvic anatomy 3 months after reconstructive surgery. Full mesh course in addition to important pelvic structures were reconstructed using the 3D Slicer® software program based on T1w and T2w MRI.
RESULTS: Three women with POP-Q grade III cystoceles were successfully treated with a partially absorbable MRI-visible anterior vaginal mesh with six fixation arms and showed no recurrent cystocele at the 3-month follow-up examination. The course of mesh in the pelvis was visible on MRI in all three women. The mesh body and arms could be reconstructed allowing visualization of the full course of the mesh in relationship to important pelvic structures such as the obturator or pudendal vessel nerve bundles in 3D.
CONCLUSIONS: The use of MRI-visible Fe3O4 polypropylene meshes in combination with post-surgical 3D reconstruction of the mesh and adjacent structures is feasible suggesting that it might be a useful tool for evaluating mesh complications more precisely and a valuable interactive feedback tool for surgeons and mesh design engineers.

Entities:  

Keywords:  3D mesh reconstruction; Fe3O4; MRI-visible anterior mesh; Pelvic floor mesh surgery; Pelvic organ prolapse

Mesh:

Substances:

Year:  2017        PMID: 28124074      PMCID: PMC6085093          DOI: 10.1007/s00192-017-3263-1

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  22 in total

1.  Procedures for pelvic organ prolapse in the United States, 1979-1997.

Authors:  Sarah Hamilton Boyles; Anne M Weber; Leslie Meyn
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

2.  Measurement of the 3D geometry of the fascial arches in women with a unilateral levator defect and "architectural distortion".

Authors:  Kindra A Larson; Jiajia Luo; Aisha Yousuf; James A Ashton-Miller; John O L Delancey
Journal:  Int Urogynecol J       Date:  2011-08-05       Impact factor: 2.894

3.  Three-dimensional analysis of implanted magnetic-resonance-visible meshes.

Authors:  Nikhil Sindhwani; Andrew Feola; Frederik De Keyzer; Filip Claus; Geertje Callewaert; Iva Urbankova; Sebastien Ourselin; Jan D'hooge; Jan Deprest
Journal:  Int Urogynecol J       Date:  2015-03-24       Impact factor: 2.894

4.  Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050.

Authors:  Jennifer M Wu; Amie Kawasaki; Andrew F Hundley; Alexis A Dieter; Evan R Myers; Vivian W Sung
Journal:  Am J Obstet Gynecol       Date:  2011-04-02       Impact factor: 8.661

5.  Lower exposure rates of partially absorbable mesh compared to nonabsorbable mesh for cystocele treatment: 3-year follow-up of a prospective randomized trial.

Authors:  J Farthmann; D Watermann; A Niesel; C Fünfgeld; A Kraus; F Lenz; H J Augenstein; E Graf; B Gabriel
Journal:  Int Urogynecol J       Date:  2012-08-29       Impact factor: 2.894

6.  Cystocele recurrence after anterior colporrhaphy with and without mesh use.

Authors:  Vivien Wong; Ka Lai Shek; Judith Goh; Hannah Krause; Andrew Martin; Hans Peter Dietz
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-11-09       Impact factor: 2.435

7.  Magnetic resonance-visible polypropylene mesh for pelvic organ prolapse repair.

Authors:  Kerstin A Brocker; Florian Lippus; Céline D Alt; Peter Hallscheidt; Fejér Zsolt; Irina Soljanik; Florian Lenz; Michael Bock; Christof Sohn
Journal:  Gynecol Obstet Invest       Date:  2014-12-20       Impact factor: 2.031

8.  Transobturator mesh for cystocele repair: a short- to medium-term follow-up using 3D/4D ultrasound.

Authors:  K L Shek; H P Dietz; A Rane; S Balakrishnan
Journal:  Ultrasound Obstet Gynecol       Date:  2008-07       Impact factor: 7.299

9.  In vivo MRI visualization of mesh shrinkage using surgical implants loaded with superparamagnetic iron oxides.

Authors:  Nicolas Kuehnert; Nils A Kraemer; Jens Otto; Hank C W Donker; Ioana Slabu; Martin Baumann; Christiane K Kuhl; Uwe Klinge
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

10.  Magnetic resonance-visible meshes for laparoscopic ventral hernia repair.

Authors:  Gernot Köhler; Leo Pallwein-Prettner; Oliver Owen Koch; Ruzica Rosalia Luketina; Michael Lechner; Klaus Emmanuel
Journal:  JSLS       Date:  2015 Jan-Mar       Impact factor: 2.172

View more
  3 in total

1.  3D Models of Female Pelvis Structures Reconstructed and Represented in Combination with Anatomical and Radiological Sections.

Authors:  L Asensio Romero; M Asensio Gómez; A Prats-Galino; J A Juanes Méndez
Journal:  J Med Syst       Date:  2018-01-15       Impact factor: 4.460

2.  Preparation and Biocompatibility Study of Contrast-Enhanced Hernia Mesh Material.

Authors:  Xuzhong Ding; Jiachen Zhu; Anning Liu; Qiyang Guo; Qing Cao; Yu Xu; Ye Hua; Yumin Yang; Peng Li
Journal:  Tissue Eng Regen Med       Date:  2022-05-25       Impact factor: 4.451

3.  A prospective pilot study on MRI visibility of iron oxide-impregnated polyvinylidene fluoride mesh after ventral rectopexy.

Authors:  K E Laitakari; J K Mäkelä-Kaikkonen; E Pääkkö; P Ohtonen; T T Rautio
Journal:  Tech Coloproctol       Date:  2019-07-03       Impact factor: 3.781

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.